From: Tumor-derived extracellular vesicles: reliable tools for Cancer diagnosis and clinical applications
Cancer | miRNAs considered as biomarkers | Source | Reference |
---|---|---|---|
Acute myeloid leukemia | miR-150, miR-1246, miR-155 | Serum | [90] |
Bladder | miR-15b, miR-24, miR-135b, miR-1224-3p | Urine | [91] |
miR-21, miR-4454 | Urine | [92] | |
Breast | miR-200a, miR-200c, miR-205 | Serum | [93] |
miR-10, miR-21, miR-182, miR-373, miR-1246 | Serum | [94] | |
Cervical | miR-21, miR-146a | Cervical lavages | [95] |
Colorectal | miR-23a, miR-1229, miR-1246, miR-let-7a, miR-150, miR-21, miR-223 | Serum | [96] |
let7a, miR-21, miR-192, miR-221 | Serum | [97] | |
Esophageal | miRNA-21 | Serum | [98] |
Glioma | miR-320, miR-574-3p | Serum | [99] |
miR-21 | CSF | [100] | |
Lung | miR-155,miR-17-3p, miR-205, miR-21, miR-106a, miR-146, miR-191, miR-192, miR-212, miR-214 miR-203, miR-210 | Plasma and Bronchoalveolar | [101] |